• 0

    24 Years of History

  • 0 & 0+

    100+ Professionals in Beijing, Shanghai, Los Angeles and San Francisco

  • 0+

    500+ Closed Deals
    Since Our Launch

  • $0B+

    $70+ billion in Deal Value

About Us

Founded in 2000, CEC Capital Group (formerly known as China eCapital Corporation) is a leading investment bank in China with a core focus on the TMT, consumer and healthcare sectors.

Headquartered in Beijing with offices in Shanghai, Los Angeles and San Francisco, we provide M&A, capital raising, and asset management services to our clients both in and outside of China.

To ensure that our clients have the best access to capital markets, we have developed an unparalleled network of institutional investors and corporate buyers. Our ECM team systematically cover over 6,000 institutional investors, which range from large conglomerates and industry heavyweights, public companies, financial institutions, government-backed funds, family offices, to venture capital, private equity, mutual fund and hedge fund players.

We provide investment banking and asset management services to our clients worldwide.On the investment banking side, our core businesses include private placements and M&A advisory services.  Over the past three years, we have raised over $20 billion for our clients.On the asset management side, we are currently managing an RMB fund and a US dollar fund, with total AUM close to $500 million.

October 2016, we acquired Siemer & Associates, a licensed US boutique investment bank. The launch of our US offices and the continuous expansion of our US team have further strengthened our capabilities in servicing our clients both in and outside of China in cross-border transactions.

Management Team

  • Ran Wang

    Founding Partner and CEO

    • Over 25 years of experience in investment banking
    • Previously worked at JP Morgan Chase and Goldman Sachs
    • BS and MBA from Harvard University
                                    
    Mr. Wang has 25 years of investment banking experience and is widely recognized as one of the most influential figures and pioneers in China's investment banking industry. He founded CEC Capital Group (formerly known as China eCapital Group) in 2000 and is now chairman and CEO of the firm. Under his leadership, CEC Capital, which has closed over 500 transactions with total deal value exceeding RMB500 billion, has emerged as a leading private investment bank and asset management firm with a core focus on the TMT, consumer and healthcare sectors. 
    
    Mr. Wang started his investment banking career at Goldman Sachs in 1994. Prior to founding CEC Capital, he had spent the previous three years with the Global M&A Group of JP Morgan, where he was responsible for developing and executing a number of large M&A transactions in the Asia-Pacific region. Mr. Wang has a bachelor degree in economics from Harvard College and an MBA from Harvard Business School. He has published extensively in leading Chinese financial press.
  • Irene Hong

    Founding Partner

    • Over 20 years of experience in investment banking and the healthcare industry
    • Previously worked at Merck and Accenture
    • BS in Mechanical Engineering and MBA from U.C. Berkeley
                                    
    Ms. Hong is a founding partner for CEC Capital Group, and leads the healthcare industry group.  Under her guidance, CEC Capital has emerged as a leader in the healthcare banking sector with the largest specialized team covering pharma/biotech, medtech, services, and digital healthcare.  Notable clients include Arrail Dental, Berry Genomics, China Medical Diagnostics Corporation, Righton Bio, Sino-Kor Hospital, and Reach Surgical.  CEC Capital also has a strong cross-border practice, having worked in the past with several multinational companies including Zimmer, Charles River, and Teva.  With an increasing interest in China outbound investment, CEC Capital has opened an office in the US and Ms. Hong will be leading this cross-border effort.  
    
    Prior to joining CEC Capital, Ms. Hong was a Manager for Accenture’s (formerly Andersen Consulting) Strategic Services practice in San Francisco.   Before receiving her MBA, Ms. Hong worked as an engineer for Merck and worked on several plant start-ups, including a technology transfer project in China for a recombinant Hepatitis B vaccine, and for Merck’s launch of Crixivan, a protease inhibitor for HIV. 
    
    Ms. Hong has both her MBA and BS in Mechanical Engineering from UC Berkeley.
  • Gang Li

    Partner

    • Over 10 years experience in investment banking
    • Previously worked at IBD, CITIC Securities 
    • Master in Finance and Financial Management from Berlin School of Economics and Law
    
                                    
    Mr. Li once served as the Senior Vice President at CITIC Securities and participated in various projects covering refinancing, overseas M&A, asset restructuring and financial advising services. Since 2012, he has been focusing on the medical and healthcare industry. He has provided a full range of investment banking services for many distinguished companies such as Dianhong Pharmaceutical, Yiling Pharmaceutical, Yifeng Pharmacy, Shineway Pharmaceutical, Jointown Pharmaceutical and Huahai Pharmaceutical. During his tenure in CITIC Securities, he also directly promoted and participated in the establishment and implementation of several fund and asset management programs.
    
    Mr. Li holds a Master’s degree in International Finance and Finance Management from the Berlin School of Economics and Law, and is fluent in German and English.
  • Michael Xu

    Partner

    • Over 10 years of experience in investment management
    • Previously worked at FountainVest Partners and the New York City Employee Retirement System
    • BS from New York University Stern School of Business and LLM from Peking University Law School
    
                                    
    Mr. Xu is a partner of CEC Capital and is the Managing Partner of CEC Future Industry Private Equity Fund. In his over ten-year career as a professional investor, Mr. Xu has managed more than USD 4 billion globally.  He started his investment career in 2006 at the New York City Employee Retirement System, which managed USD 220 billion, and was responsible for their emerging market private equity investments.  Before joining CEC Capital, Mr. Xu worked at FountainVest Partners, one of the largest private equity funds in China. 
    
    Mr. Xu holds a Bachelor’s degree from New York University’s Stern School of Business and an LLM from Peking University Law School.
  • Kevin Wang

    Partner

    • Over 10 years of investment and management experience in entertainments, sports, TMT, and the consumer industry
    • Previously worked at Fosun, Roland Berger and General Mills
    • BS from Ohio State University and MBA from Oxford University
    
                                    
    As a veteran investor, Mr. Wang has rich experience in domestic and foreign investment, management consulting and business operations.  
    
    His career began at the US-based General Mills, where he participated in and completed the largest M&A transactions in the company’s history.  After returning to China, he worked at Roland Berger as a senior consultant in consumer goods, healthcare and other industries.  In 2010, Mr. Wang joined CEC Capital and during the four years spent here, he completed financing and M&A transactions worth over RMB 10 billion before leaving as the senior director of M&A.  In 2014, he joined the Fosun Group where he served as the Executive Director of International Development Department and China Momentum Fund and led a number of investments in Infront Sports & Media, DTZ Zadelhoff, and other companies.  In 2016, he returned to CEC and as a founder of the RMB fund, where he serves as a fund partner and member of the Investment Committee.
    
    Mr. Wang holds an MBA from Oxford University and a BS degree in Management from Ohio State University.